112
Views
1
CrossRef citations to date
0
Altmetric
Research Article

Early pregnancy exposure to feto-toxic medications among out-patients in Malawi

, , , &
Pages 1204-1208 | Received 25 Jul 2013, Accepted 25 Oct 2013, Published online: 29 Nov 2013

References

  • Malm H, Martikainen J, Klaukka T, Neuvonen PJ. Prescription of hazardous drugs during pregnancy. Drug Safety 2004;27:899–908
  • Manyando C, Mkandawire R, Puma L, et al. Safety of artemether-lumefantrine in pregnant women with malaria: results of a prospective cohort study in Zambia. Malar J 2010;9:249
  • Holst L, Wright D, Haavik S, Nordeng H. The use and user of herbal remedies during pregnancy. J Altern Complement Med 2009;7:787–92
  • Tagbor H, Bruce J, Browne E, et al. Efficacy, safety, and tolerability of amodiaquine plus sulphadoxinepyrimethamine used alone or in combination for malaria treatment in pregnancy: a randomized trial. Lancet 2006;368:1349–56
  • Kebede B, Gedif T, Getachew A. Assessment of drug use among pregnant women in Addis Ababa, Ethiopia. Pharmacoepidemiol Drug Safety 2009;18:464–8
  • Stanback J, Nanda K, Ramirez Y, et al. Validation of a job aid to rule out pregnancy among Family Planning clients in Nicaragua. Rev Panam Salud Publica 2008;23:116–18
  • Pell C, Meňaca A, Were F, et al. Factors affecting antenatal clinic attendance: results from qualitative studies in Ghana, Kenya and Malawi. PLoS ONE 2013;8:e53747
  • Rutishauser C, Esslinger A, Bond L, Sennhauser FH. Consultations with adolescents: the gap between their expectations and experiences. Acta Paediatr 2003;92:1322–6
  • World Health Organisation. Use of Efavirenz during pregnancy: a public health perspective. Geneva; 2012
  • Kinney MV, Kerber KJ, Black RE, et al. Sub-Saharan African mothers, newborns and children: where and why do they die? PLoS Med 2010;7:e1000294
  • Ochako R, Fotso J-C, Ikamari L, Khasakhala A. Utilisation of maternal health services among women in Kenya: insights from the Kenya Demographic and Health Survey 2003. BMC Preg Childbirth 2011;11:1
  • Drug Safety Site. Drug safety during pregnancy and breastfeeding. Available from: http://thedrugsafety.com/in_pregnancy/ [last accessed 5 June 2013]
  • Sevene E, Bardajĭ A, Mariano A, et al. Drug exposure and pregnancy outcome in Mozambique. Pediatr Drugs 2012;14:43–9
  • Brabin BJ. An analysis of malaria in pregnancy. Bull WHO 1983;61:1005–16
  • Eze UI, Eferakeya AE, Oparah A, Enato EF. Assessment of prescription profiles of pregnant women visiting antenatal clinics. Phar Prac 2007;5:135–9
  • McGready R, Lee SJ, Wiladphaingern J, et al. Adverse effects of falciparum and vivax malaria and safety of antimalarial treatment in early pregnancy: a population-based study. Lancet Infect Dis 2012;12:388–96
  • Jungmann EM, Mercey D, DeRuiter A, et al. Is first trimester exposure to the combination of antiretroviral therapy and folate antagonists a risk factor for congenital abnormalities? Sex Trans Inf 2001;77:441–3
  • World Health Organisation. Country co-operation strategy. Available from: http://www.who.int/countryfocus/cooperation_strategy/ccsbrief_mwi_en.pdf [last accessed 05 June 2013]
  • Nezvalová-Henriksen K, Spigset O, Nordeng H. Effects of ibuprofen, diclofenac, naproxen, and piroxicam on the course of pregnancy and pregnancy outcome: a prospective cohort study. BJOG 2013;1208:948--59
  • Malawi Standard Treatment Guidelines (MSTG). 4th Edition 2009. Incorporating Malawi Essential Medicine List (MEML) 2009. Ministry of Health, Lilongwe
  • Bardaji A, Sigauque B, Bruni L, et al. Clinical malaria in African pregnant women. Mal J 2008;7:27
  • Herring A, Ballard R, Mabey D, Peeling RW. Evaluation of rapid diagnostic tests: chlamydia and gonorrhoea. Nat Rev Microbiol 2006;S41–6. doi:10.1038/nrmicro1562
  • Gallo MF, Nghia NC. Real life is different: a qualitative study of why women delay abortion until the second trimester in Vietnam. Soc Sci Med 2007;64:1812–22
  • Morgan MA, Cragan JD, Goldenberg RL, et al. Management of prescription and non-prescription drugs during pregnancy. J Mat Fet Neonat Med 2010;23:813–19
  • Schwartz EB, Maselli J, Norton M, Gonzales R. Prescription of teratogenic medications in United States ambulatory practices. Am J Med 2005;118:1240–9
  • Launiala A, Honkasolo M. Ethnographic study of factors influencing compliance to intermittent preventive treatment of malaria during pregnancy among Yao women in rural Malawi. Trans Roy Soc Trop Med Hyg 2007;101:980–9
  • Brabin L, Stokes E, Dumbaya I, Owens S. Rural Gambian women’s reliance on health workers to deliver sulphadoxine-pyrimethamine as recommended intermittent preventive treatment for malaria in pregnancy. Mal J 2009;8:25–31
  • Bello F Morhason-Bello I, Olayemi O, Adekunle A. Patterns and predictors of self medication amongst antenatal clients in Ibadan, Nigeria. Nig Med J 2011;52:153–7
  • Dellicour S, ter Kuile FO, Stergachis A. Pregnancy exposure registries for assessing antimalarial drug safety in pregnancy in malaria-endemic countries. PLoS Med 2008;5:e187

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.